radiation syndrome


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.radiation syndrome - syndrome resulting from exposure to ionizing radiation (e.g., exposure to radioactive chemicals or to nuclear explosions); low doses cause diarrhea and nausea and vomiting and sometimes loss of hair; greater exposure can cause sterility and cataracts and some forms of cancer and other diseases; severe exposure can cause death within hours; "he was suffering from radiation"
syndrome - a pattern of symptoms indicative of some disease
References in periodicals archive ?
TM](oral beclomethasone 17,21-dipropionate or oral BDP) for the mitigation of morbidity and mortality associated with the gastrointestinal acute radiation syndrome (GI-ARS).
Cellerant is also developing CLT-008 for the treatment of Acute Radiation Syndrome (ARS) under a United States Government contract awarded on September 1, 2010 and valued up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services.
BDP is the active ingredient in OrbeShield (TM), currently being developed for the treatment of gastrointestinal acute radiation syndrome (GI ARS), the driving component in early mortality following high doses of total body irradiation (TBI).
Avaxia also has programs in GI acute radiation syndrome, celiac disease, oral mucositis and diabetes.
On October 3, 2012, the Company announced the formation of a Scientific Advisory Board (SAB) to provide strategic guidance to the Company as it relates to the development of OrbeShield (TM)(oral BDP) for the treatment of gastrointestinal acute radiation syndrome (GI-ARS).
OTC: AOLS), a biopharmaceutical company developing a new class of broad spectrum catalytic antioxidant compounds that reduce oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure, today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), has awarded Aeolus a contract for the advanced development of AEOL 10150 as a medical countermeasure (MCM) against the pulmonary sub-syndrome of acute radiation syndrome (ARS).
1 million to Soligenix to advance OrbeShield(TM) as a medical countermeasure (MCM) for the treatment of gastrointestinal acute radiation syndrome (GI ARS).
The award will back the ongoing advanced development of CLT-008, a first-in-class, allogeneic, cell-based therapy to treat hematopoietic sub-syndrome of Acute Radiation Syndrome (ARS).
Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
Revenues included contracts with the US Department of Health and Human Service's Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID) in support of OrbeShield(TM) (oral beclomethasone 17,21-dipropionate or BDP) development for the treatment of gastrointestinal acute radiation syndrome (GI ARS) and a contract with NIAID to advance the development of RiVax(TM), its proprietary ricin toxin vaccine, in conjunction with its heat stabilization technology, ThermoVax(TM), as a medical countermeasure to prevent the effects of ricin exposure.
Contract Awarded for the advanced preclinical development of OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) as a MCM for the treatment of gastrointestinal acute radiation syndrome (GI ARS)
Department of Defense (DoD) to develop BIO 300 as a new medical radiation countermeasure (MRC) for lethal exposure to radiation, also known as Acute Radiation Syndrome (ARS).